loadpatents
name:-0.03692102432251
name:-0.023610830307007
name:-0.0036211013793945
Marom; Ehud Patent Filings

Marom; Ehud

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marom; Ehud.The latest application filed is for "glatiramer depot systems for treating progressive forms of multiple sclerosis".

Company Profile
3.34.46
  • Marom; Ehud - Tel Aviv IL
  • Marom; Ehud - Kfar Sava IL
  • Marom; Ehud - Kfar Saba IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
Grant 11,413,311 - Marom , et al. August 16, 2
2022-08-16
Glatiramer Depot Systems For Treating Progressive Forms Of Multiple Sclerosis
App 20220023377 - DANON; Uri ;   et al.
2022-01-27
Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
Grant 11,167,003 - Danon , et al. November 9, 2
2021-11-09
Process For Preparing Microparticles Containing Glatiramer Acetate
App 20210299057 - BLEICH KIMELMAN; Nadav ;   et al.
2021-09-30
Depot Systems Comprising Glatiramer Acetate
App 20210283209 - MAROM; Ehud ;   et al.
2021-09-16
Treatment Of Inflammatory Bowel Disease With Long Acting Glatiramer And Adipose-derived Stem Cells
App 20210220428 - MAROM; Ehud ;   et al.
2021-07-22
Glatiramer Depot Systems For Treating Progressive Forms Of Multiple Sclerosis
App 20200376069 - DANON; Uri ;   et al.
2020-12-03
Treatment Of Multiple Sclerosis With Adipose-derived Stem Cells
App 20200188439 - MAROM; Ehud ;   et al.
2020-06-18
Treatment Of Multiple Sclerosis With Long Acting Glatiramer And Adipose-derived Stem Cells
App 20200147141 - MAROM; Ehud ;   et al.
2020-05-14
Sublingual delivery of glatiramer acetate
Grant 10,493,122 - Sela , et al. De
2019-12-03
Process and intermediates for the preparation of perampanel
Grant 10,111,867 - Marom , et al. October 30, 2
2018-10-30
Amorphous form of apremilast
Grant 9,994,522 - Rubnov , et al. June 12, 2
2018-06-12
Process And Intermediates For The Preparation Of Perampanel
App 20180008584 - MAROM; Ehud ;   et al.
2018-01-11
Amorphous Form Of Apremilast
App 20170174626 - RUBNOV; Shai ;   et al.
2017-06-22
Intermediate compounds and process for the preparation of efinaconazole
Grant 9,617,241 - Gopin , et al. April 11, 2
2017-04-11
Sublingual Delivery Of Glatiramer Acetate
App 20170080044 - SELA; Yoram ;   et al.
2017-03-23
Intermediate Compounds And Process For The Preparation Of Efinaconazole
App 20160355500 - GOPIN; Anna ;   et al.
2016-12-08
Polymorphs of darunavir
Grant 9,453,024 - Marom September 27, 2
2016-09-27
Stem Cell Bank For Personalized Medicine
App 20160122709 - MAROM; Ehud
2016-05-05
Amorphous form of dolutegravir
Grant 9,206,197 - Marom , et al. December 8, 2
2015-12-08
Random pentapolymer for treatment of autoimmune diseases
Grant 9,200,114 - Marom , et al. December 1, 2
2015-12-01
Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
Grant 9,102,592 - Marom , et al. August 11, 2
2015-08-11
Polymorphs of perampanel
Grant 9,096,574 - Marom , et al. August 4, 2
2015-08-04
Polymorphs Of Darunavir
App 20150148412 - MAROM; Ehud
2015-05-28
Co-crystals of dapagliflozin
Grant 9,006,188 - Marom , et al. April 14, 2
2015-04-14
Intermediate compounds and process for the preparation of lurasidone and salts thereof
Grant 8,981,095 - Marom , et al. March 17, 2
2015-03-17
Process and intermediates for the preparation of abiraterone acetate
Grant 8,975,244 - Marom , et al. March 10, 2
2015-03-10
Intermediate Compounds And Processes For The Preparation Of Quinoline Derivatives Such As Laquinimod Sodium
App 20150051419 - MAROM; Ehud ;   et al.
2015-02-19
Polymorphs of darunavir
Grant 8,921,415 - Marom December 30, 2
2014-12-30
Polymorphs Of Perampanel
App 20140371273 - Marom; Ehud ;   et al.
2014-12-18
Amorphous Form Of Dolutegravir
App 20140350004 - Marom; Ehud ;   et al.
2014-11-27
Co-crystals Of Dapagliflozin
App 20140343010 - MAROM; Ehud ;   et al.
2014-11-20
Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
Grant 8,865,742 - Marom , et al. October 21, 2
2014-10-21
Insurance Policies For Stem Cells Depositors And Methods For Providing Same
App 20140304012 - Marom; Ehud
2014-10-09
Process for the preparation of alogliptin
Grant 8,841,447 - Marom , et al. September 23, 2
2014-09-23
Process for the preparation of darunavir and darunavir intermediates
Grant 8,829,208 - Mizhiritskii , et al. September 9, 2
2014-09-09
Process And Intermediates For The Preparation Of Substituted 2-arylthiazole Carboxylic Acids
App 20140228417 - Mizhiritskii; Michael ;   et al.
2014-08-14
Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
Grant 8,796,226 - Marom , et al. August 5, 2
2014-08-05
Processes for the preparation of deferasirox, and deferasirox polymorphs
Grant 8,772,503 - Mizhiritskii , et al. July 8, 2
2014-07-08
Intermediate Compounds And Process For The Preparation Of Lurasidone And Salts Thereof
App 20140179922 - Marom; Ehud ;   et al.
2014-06-26
Process And Intermediates For The Preparation Of Abiraterone Acetate
App 20140155363 - MAROM; Ehud ;   et al.
2014-06-05
Intermediate compounds and process for the preparation of fingolimod
Grant 8,735,627 - Marom , et al. May 27, 2
2014-05-27
Intermediate Compounds And Processes For The Preparation Of Quinoline Derivatives Such As Laquinimod Sodium
App 20130245065 - Marom; Ehud ;   et al.
2013-09-19
Polymorphs Of Febuxostat
App 20130225830 - Marom; Ehud ;   et al.
2013-08-29
Intermediate Compounds And Process For The Preparation Of Fingolimod
App 20130217899 - Marom; Ehud ;   et al.
2013-08-22
Random Pentapolymer For Treatment Of Autoimmune Diseases
App 20130156725 - MAROM; Ehud ;   et al.
2013-06-20
Intermediate compounds and processes for the preparation of tapentadol and related compounds
Grant 8,410,176 - Marom , et al. April 2, 2
2013-04-02
Polymorphs Of Alogliptin Benzoate
App 20130059872 - Marom; Ehud ;   et al.
2013-03-07
Stem Cell Bank For Personalized Medicine
App 20130052169 - Marom; Ehud
2013-02-28
Preparation Of Benzofurans And Use Thereof As Synthetic Intermediates
App 20130046103 - Marom; Ehud ;   et al.
2013-02-21
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
Grant 8,377,885 - Marom , et al. February 19, 2
2013-02-19
Polymorphs Of Darunavir
App 20130023570 - MAROM; Ehud
2013-01-24
Process For The Preparation Of Darunavir And Darunavir Intermediates
App 20120296101 - Mizhiritskii; Michael ;   et al.
2012-11-22
Intermediate Compounds And Processes For The Preparation Of Tapentadol And Related Compounds
App 20120283463 - Marom; Ehud ;   et al.
2012-11-08
Processes For The Preparation Of Deferasirox, And Deferasirox Polymorphs
App 20120245361 - Mizhiritskii; Michael ;   et al.
2012-09-27
Depot Systems Comprising Glatiramer Or Pharmacologically Acceptable Salt Thereof
App 20120164229 - MAROM; Ehud ;   et al.
2012-06-28
Polymorphs Of Darunavir
App 20120035142 - Marom; Ehud
2012-02-09
Process For The Preparation Of Alogliptin
App 20120029000 - Marom; Ehud ;   et al.
2012-02-02
Depot Systems Comprising Glatiramer Or A Pharmacologically Acceptable Salt Thereof
App 20120015891 - Marom; Ehud ;   et al.
2012-01-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed